Home » stock rating

stock rating

Feb 15, 2018

Foundation Medicine Coverage Initiated by Cowen

The investment bank gave the company's stock an Outperform rating with a target price of $90 per share.

Dec 13, 2017

JP Morgan Downgrades Genomic Health to Underweight

The investment bank previously had a Neutral rating for the company, and it lowered the price target on Genomic Health's stock to $25 from $28. 

Oct 04, 2016

First Analysis Initiates Coverage of NeoGenomics at Overweight

The investment bank said NeoGenomics and its clients are likely to benefit from a product portfolio expanded by the acquisition of Clarient.

Jan 05, 2016

GenomeWeb Index Rises 5 Percent in 2015, Led by PacBio; Fluidigm Leads Decliners

There were more winners than losers in the 2015 GWDN Index, but some lost big.

Dec 14, 2015

Raymond James Downgrades Quidel's Stock

The bank downgraded Quidel's shares to market perform and trimmed its Q4 revenue forecast due to a mild flu season.

Sep 02, 2015

Barclays Initiates Coverage on Genomic Health, Quidel, Cepheid; Upgrades Hologic

The investment firm has added the three companies to its US Life Science Tools & Diagnostics coverage while upping Hologic to an Equal Weight rating.

May 21, 2015

Investment Banks Downgrade Bruker on Resignation of CFO

Mizuho and William Blair downgraded Bruker, following the resignation of CFO Charles Wagner, who was noted for his role in implementing a turnaround at the company.

Jun 20, 2014

Piper Jaffray Initiates Coverage of Veracyte with Overweight Rating

NEW YORK (GenomeWeb) – Investment bank Piper Jaffray on Thursday initiated coverage of Veracyte with an overweight rating on the firm's stock and a $21 price target.

Sep 18, 2013

Piper Jaffray Initiates Coverage of PerkinElmer with Overweight Rating

NEW YORK (GenomeWeb News) – Investment bank Piper Jaffray has initiated coverage of PerkinElmer with an Overweight rating and a $46 price target.

Jan 22, 2013

Analysts Speculate on Potential Life Technologies Sale

NEW YORK (GenomeWeb News) – Following a spike in Life Technologies' share price after a report that the company may be searching for a buyer, investment firm William Blair today downgra

Pages

The Scan

Building Up Numbers

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Slow Coverage

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

Many Choices

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

This Week in Nature

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.